Navigation Links
Experimental vaccine for shingles is effective

Researchers have discovered a newer form of chicken pox vaccine to// effectively control the painful condition called shingles.

Shingles (also known as herpes zoster) is the condition that gets symptoms of rashes or blisters on the skin, along with sensations of burning pain, tingling, and numbness on the area. There may be fever with chills, headache or upset stomach. The infection is somewhat like chicken pox and is caused by the same virus varicella-zoster. Anyone who had chicken pox once is at a risk. Scientists say that the chicken pox virus moves into the nervous system after the attack, and reactivates as shingles.

The new vaccine called zoster vaccine is a more potent version of the chicken pox vaccine that’s available for the children. This vaccine contains live and weak form of the varicella-zoster virus that causes chicken pox. The vaccine had been able to prevent the occurrence of shingles for half the people who received it, and reduced significantly the severity and complications of the disease in most of the vaccinated people.

Shingles is a condition that keeps on affecting people and affects the elderly people more severely. The new vaccine for adults will now be able to bring relief to all people who have been suffering from the disease.

The research will be published in the new edition of New England Journal of Medicine.
'"/>




Page: 1

Related medicine news :

1. Experimental treatment for Ebola Virus Shows promising results in mice
2. Experimental drug to fight flu
3. Experimental SARS Vaccine
4. Experimental Blood Test May Spot Heart Attack Risk, Study Says
5. Five AIDS Patients To Receive Experimental Anti-retroviral Drugs
6. Protection against HIV and Herpes is possible with the Experimental Microbicide
7. Experimental Therapy Effective Against Malignant Melanoma in Horses
8. Experimental Alzheimer’s Drug curbs the disease in mic
9. New Guidelines to Be Laid While Testing Experimental Drugs
10. Experimental Drug Deals Effectively with Prostate Cancer Cells
11. Experimental Drug Causes Cytokine Storm
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... ... 06, 2016 , ... The Behavioral Health Center of Excellence ... organization as a top behavioral service provider in the country. The award celebrates ... satisfaction and qualifications, and consumer satisfaction. These areas are measured via a wide-ranging ...
(Date:12/6/2016)... Cary, NC (PRWEB) , ... December 06, 2016 ... ... cancer research charity, is thrilled to formally announce its Not a Moment to ... Moment to Lose will rally supporters dedicated to declaring victory over cancer. The ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... is now offering HIAC particle counting and sizing services for USP 788 and ... instituted the new service as a response to the needs of pharmaceutical and ...
(Date:12/6/2016)... ... 06, 2016 , ... METTLER TOLEDO has launched its online ... white papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, brochures, datasheets, user ... documents, webinars and videos available online, visit the METTLER TOLEDO Expertise Library ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble ... Featuring one of the world’s most powerful antioxidants, molecular hydrogen, HydroFX for ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... NEW YORK , Dec. 5, 2016 /PRNewswire/ ... of penicillin in 1948, antibiotics have emerged as ... treating several infectious conditions. In addition, antibiotics are ... have undergone surgery, or immunocompromised patients (cancer patients ... both in healthcare and food production, has rapidly ...
(Date:12/5/2016)... 29, 2016 Several leading Alzheimer,s disease experts ... Inc. at 11 a.m. EST on December 6 ... Clinical Trials for Alzheimer,s Disease (CTAD). The program will ... disease and therapeutic targets that address deficient glucose metabolism ... recent failure of another therapy targeting the amyloid hypothesis, ...
(Date:12/5/2016)... Research and Markets has announced the addition of the ... Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & ... offering. ... The western blotting market is expected ... in 2016, growing at a CAGR of 4.9%. ...
Breaking Medicine Technology: